OrSense gets venture loan

The company has developed a non-invasive continuous monitor of blood glucose for people with diabetes.

Medical device start-up OrSense Ltd. is raising a new financing round. Sources inform ''Globes'' that the company is obtaining a $3-4 million venture loan. The company, which has developed a non-invasive continuous monitor of blood glucose for people with diabetes, has raised $28 million to date.

OrSense obtained EU CE Mark certification for its NBM-200G monitor in June. The company has also won the Frost and Sullivan 2006 Technology Innovation Award.

Published by Globes [online], Israel business news - www.globes.co.il - on November 1, 2007

© Copyright of Globes Publisher Itonut (1983) Ltd. 2007

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018